Our objective at Onxeo is to maintain an open, rich dialogue with our shareholders, our potential investors and the financial community at large. We keep you informed on a regular basis of the progress made by the Company in order to help you with your analysis and make it easier for you to understand the Company’s added value.

Agenda >

Meetings with investors in San Francisco, CA during the JP Morgan Healthcare Conference

January 9-12, 2017

BioMed Event by Invest Securities

January 26, 2017

FY 2016 Results & Business Update - Presentation to the French Society of Financial Analysts (SFAF)

March 8, 2017

AACR Annual Meeting 2017

April 1-5, 2017

Future Leaders in the Biotech Industry by Biocentury

April 7, 2017